Gentex
GNTX
21.08
-0.35
-1.63%
Gentex
US · GNTX
#2186 by market cap
Listed 1970
21.08
-0.35
-1.63%
Live - 5344 symbols - heartbeat 78s ago
· 2026-10-08 07:37
Pre-market
21.00
-0.38%
After-hours
21.12
+0.19%
- Market cap
- 4.44B
- P/E (TTM)i
- 11.15
- P/Bi
- 1.75
- EPSi
- 1.74
- Div yieldi
- 2.28%
- 52W posi
- 15%
Reader sentiment
Are you bullish or bearish on GNTX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 8.51, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +9.55% YoY
Margins
- Gross margin
- 34.20%
- Operating margin
- 19.16%
- Net margin
- 14.96%
Key ratios & quality
- PEG ratioi
- 1.72
- Altman Z-Scorei
- 8.51
PEG uses trailing P/E against the 3-year net income growth rate (6.48%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.83B | 1.86B | 1.69B | 1.73B | 1.92B | 2.30B | 2.31B | 2.53B |
| Gross profit | 690.47M | 688.31M | 605.44M | 619.71M | 609.81M | 762.63M | 771.09M | 866.71M |
| Selling & admin expenses | 75.21M | 85.08M | 89.95M | 92.16M | 106.50M | 112.54M | 121.02M | 177.87M |
| Research & development | 107.13M | 114.69M | 115.94M | 117.76M | 133.31M | 154.36M | 181.48M | 203.26M |
| Operating profit | 508.13M | 488.54M | 399.56M | 409.78M | 370.01M | 495.73M | 468.59M | 485.58M |
| Pretax profit | 522.05M | 500.42M | 411.81M | 416.35M | 369.72M | 504.98M | 472.21M | 461.06M |
| Tax | 84.16M | 75.73M | 64.25M | 55.55M | 50.97M | 76.58M | 67.73M | 76.38M |
| Net profit | 437.88M | 424.68M | 347.56M | 360.80M | 318.76M | 428.40M | 404.49M | 384.68M |
| Basic EPS | 2 | 2 | 1 | 2 | 1 | 2 | 2 | 2 |
| Diluted EPS | 1.62 | 1.66 | 1.41 | 1.50 | 1.36 | 1.84 | 1.76 | 1.74 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 576.77M | 657.86M | 655.24M | 644.40M | 675.44M | 651.30M |
| Gross profit | 191.73M | 225.29M | 225.17M | 224.52M | 228.63M | 241.00M |
| Selling & admin expenses | 29.93M | 48.52M | 49.69M | 49.73M | 49.79M | 50.04M |
| Research & development | 45.92M | 51.47M | 52.63M | 53.23M | 51.65M | 49.26M |
| Operating profit | 115.88M | 125.30M | 122.85M | 121.55M | 127.18M | 141.70M |
| Pretax profit | 113.63M | 115.47M | 120.57M | 111.39M | 118.05M | 136.83M |
| Tax | 18.75M | 19.82M | 19.68M | 18.12M | 19.63M | 22.64M |
| Net profit | 94.87M | 95.65M | 100.89M | 93.27M | 98.42M | 114.18M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 1 |
| Diluted EPS | 0.42 | 0.43 | 0.46 | 0.43 | 0.46 | 0.54 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 850.93M | 950.38M | 979.33M | 872.98M | 948.65M | 997.74M | 1.04B | 1.13B |
| Cash & ST investments | 386.44M | 436.71M | 450.54M | 267.74M | 237.76M | 240.79M | 255.62M | 151.03M |
| Inventory | 225.28M | 248.94M | 226.29M | 316.27M | 404.36M | 402.47M | 436.50M | 516.25M |
| Total assets | 2.09B | 2.17B | 2.20B | 2.13B | 2.33B | 2.61B | 2.76B | 2.93B |
| Total current liabilities | 169.16M | 171.85M | 177.74M | 181.66M | 250.55M | 271.61M | 252.69M | 387.54M |
| Short-term debt | -- | -- | -- | -- | -- | -- | -- | 3.80M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 223,682,408.00 | 230,715,373.00 | 233,998,042.00 | 193,402,699.00 | 261,437,103.00 | 298,920,483.00 | 288,721,320.00 | 437,660,897.00 |
| Total equity | 1.86B | 1.94B | 1.96B | 1.94B | 2.07B | 2.31B | 2.47B | 2.49B |
| Retained earnings | 1.10B | 1.12B | 1.09B | 1.04B | 1.15B | 1.34B | 1.45B | 1.47B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.09B | 1.06B | 1.17B | 1.13B | 1.21B | 1.23B |
| Cash & ST investments | 307.11M | 141.08M | 183.40M | 151.03M | 175.05M | 242.81M |
| Inventory | 408.93M | 475.72M | 499.24M | 516.25M | 523.51M | 518.95M |
| Total assets | 2.78B | 2.81B | 2.94B | 2.93B | 3.00B | 3.00B |
| Total current liabilities | 266.63M | 336.93M | 394.46M | 387.54M | 444.58M | 405.12M |
| Short-term debt | -- | 3.93M | 4.13M | 3.80M | 3.84M | 3.71M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 303,131,725.00 | 380,689,351.00 | 441,220,168.00 | 437,660,897.00 | 492,029,538.00 | 458,495,003.00 |
| Total equity | 2.48B | 2.43B | 2.50B | 2.49B | 2.51B | 2.54B |
| Retained earnings | 1.45B | 1.42B | 1.47B | 1.47B | 1.48B | 1.52B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 552.42M | 505.97M | 464.49M | 362.17M | 338.20M | 537.25M | 498.21M | 587.13M |
| Depreciation & amortization | 102.19M | 104.70M | 104.74M | 99.11M | 96.57M | 93.32M | 94.71M | 104.04M |
| Free cash flow | 466.43M | 421.39M | 412.79M | 293.33M | 191.77M | 353.57M | 353.54M | 458.04M |
| Dividends paid | -116.57M | -116.31M | -117.18M | -115.29M | -113.09M | -112.15M | -110.44M | -106.86M |
| Stock buybacks / issuance | -591.58M | -331.47M | -288.48M | -324.64M | -112.53M | -147.40M | -206.11M | -315.50M |
| Ending cash balance | 217.03M | 296.32M | 423.37M | 262.31M | 218.75M | 226.44M | 233.32M | 145.65M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 148.51M | 166.14M | 146.98M | 125.50M | 137.08M | 184.58M |
| Depreciation & amortization | 25.51M | 27.37M | 25.93M | 25.23M | 25.66M | 25.77M |
| Free cash flow | 111.78M | 135.03M | 111.40M | 99.83M | 120.04M | 165.39M |
| Dividends paid | -27.26M | -26.98M | -26.34M | -26.27M | -25.85M | -25.56M |
| Stock buybacks / issuance | -67.83M | -131.04M | -30.15M | -86.48M | -68.64M | -69.23M |
| Ending cash balance | 286.56M | 119.77M | 181.39M | 145.65M | 164.76M | 233.44M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 22.39 | 22.35 | 17.56 | 18.21 | 15.68 | 19.28 | 16.69 | 15.30 |
| ROA %i | 19.74 | 19.97 | 15.69 | 16.41 | 14.08 | 17.09 | 14.85 | 13.33 |
| ROIC %i | 22.39 | 22.35 | 17.56 | 18.21 | 15.68 | 19.28 | 16.69 | 15.28 |
| 5-year avg ROE %i | 20.26 | 20.70 | 20.34 | 20.16 | 19.19 | 18.56 | 17.48 | 17.03 |
| EBIT margin %i | 27.70 | 26.28 | 23.67 | 23.67 | 19.28 | 21.56 | 20.26 | 19.16 |
| FCF / sales %i | 25.43 | 22.67 | 24.45 | 16.94 | 9.99 | 15.38 | 15.28 | 18.07 |
| Current ratioi | 5.03 | 5.53 | 5.51 | 4.81 | 3.79 | 3.67 | 4.11 | 2.91 |
| Quick ratioi | 3.55 | 3.91 | 4.14 | 2.85 | 2.05 | 2.07 | 2.18 | 1.34 |
| Debt / assetsi | -- | -- | -- | -- | -- | -- | -- | 0.13 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 5.92 | 3.45 | -2.02 | -1.91 | 1.07 | 10.85 | 10.15 | 9.71 |
| Net income CAGR (3Y) %i | 11.20 | 6.91 | -5.11 | -6.25 | -9.12 | 7.22 | 3.88 | 6.48 |
| FCF CAGR (3Y) %i | 22.06 | 5.77 | 1.31 | -14.32 | -23.08 | -5.03 | 6.42 | 33.67 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 15.90 | 16.35 | 15.23 | 15.30 | 15.37 | 16.16 |
| ROA %i | 14.04 | 14.22 | 13.19 | 13.33 | 13.23 | 13.81 |
| ROIC %i | 15.90 | 16.32 | 15.20 | 15.28 | 15.35 | 16.13 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 19.79 | 19.52 | 19.03 | 19.16 | 18.87 | 19.54 |
| FCF / sales %i | 15.97 | 16.98 | 19.37 | 18.07 | 17.71 | 18.91 |
| Current ratioi | 4.08 | 3.15 | 2.96 | 2.91 | 2.72 | 3.04 |
| Quick ratioi | 2.39 | 1.53 | 1.44 | 1.34 | 1.34 | 1.55 |
| Debt / assetsi | -- | 0.14 | 0.14 | 0.13 | 0.13 | 0.12 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Automotive Products is the largest reported line at 86.01% of revenue, across 3 reported segments.
- The next-largest line, Premium Audio Products, is a distant second at 7.94% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Automotive Products86.01%
Premium Audio Products7.94%
Other6.05%
Quote time 2026-10-08 07:37:19 · For reference only, not investment advice and not tailored to your situation.